In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nuclear Medicine and Biology

• Publication date

  2006-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NUCMEDBIO.2005.10.011PMID 16546677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide.

  2005cited by this paper
• Type IV collagenases in invasive tumors

  2005cited by this paper
• Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide.

  2004cited by this paper
• Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

  2004cited by this paper
• New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents.

  2004cited by this paper
• Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide.

  2004cited by this paper
• Pro-Matrix Metalloproteinase-2 Transfection Increases Orthotopic Primary Growth and Experimental Metastasis of MDA-MB-231 Human Breast Cancer Cells in Nude Mice

  2004cited by this paper
• Matrix Metalloproteinase-2 (MMP-2) is Associated with the Risk for a Relapse in Postmenopausal Patients with Node-Positive Breast Carcinoma Treated with Antiestrogen Adjuvant Therapy

  2004cited by this paper
• Performance evaluation of the microPET R4 PET scanner for rodents

  2003cited by this paper
• In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.

  2003cited by this paper
• Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor.

  2003cited by this paper
• Platelet and osteoclast β3 integrins are critical for bone metastasis

  2003cited by this paper
• Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells

  2003cited by this paper
• Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester.

  2003cited by this paper
• Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma

  2003cited by this paper
• Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.

  2003cited by this paper
• Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.

  2002cited by this paper
• Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.

  2002cited by this paper
• Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.

  2001cited by this paper
• In vivo molecular target assessment of matrix metalloproteinase inhibition

  2001cited by this paper
• Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro.

  2001cited by this paper
• In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection

  2001cited by this paper
• MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report.

  2000cited by this paper
• MMP-9 Supplied by Bone Marrow – Derived Cells Contributes to Skin Carcinogenesis

  2000cited by this paper
• Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging.

  2000cited by this paper
• MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

  2000cited by this paper
• Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.

  1999cited by this paper
• MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma

  1999cited by this paper
• Tumor targeting with a selective gelatinase inhibitor

  1999influential reference
• Changes in Matrix Metalloproteinases during the Evolution of Interstitial Renal Fibrosis in a Rat Experimental Model

  1998cited by this paper
• Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.

  1998cited by this paper
• Efficient production of high specific activity 64Cu using a biomedical cyclotron.

  1997cited by this paper
• Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media

  1996cited by this paper
• Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu.

  1996cited by this paper
• MicroPET: a high resolution PET scanner for imaging small animals

  1996cited by this paper
• The efficient production of high specific activity copper-64 using a biomedial cyclotron

  1996cited by this paper
• In vitro and in vivo evaluation of copper-64-octreotide conjugates.

  1995cited by this paper
• Low Molecular Weight Inhibitors in Corneal Ulceration a

  1994cited by this paper
• The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals.

  1994cited by this paper
• A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9).

  1993cited by this paper
• Matrix metalloproteinases and their inhibitors in connective tissue remodeling

  1991cited by this paper
• Chlamydia

  1990cited by this paper
• Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice.

  1990cited by this paper
• Metalloproteinases and their inhibitors in matrix remodeling.

  1990cited by this paper
• Solid‐phase peptide synthesis: a practical approach

  1990cited by this paper
• Type IV collagenases in tumor invasion and metastasis

  1990cited by this paper
• Proteolytic degradation of extracellular matrix in tumor invasion.

  1987cited by this paper

• Tumor-specific Peptide Probes and the Applications in Bioimaging

  2024cites this paper
• Positron emission tomography molecular imaging‐based cancer phenotyping

  2022cites this paper
• Peptide-Based Strategies for Targeted Tumor Treatment and Imaging

  2021cites this paper
• The Radiopharmaceutical Chemistry of the Radioisotopes of Copper

  2019cites this paper
• Design, (Radio)Synthesis, and in Vitro and in Vivo Evaluation of Highly Selective and Potent Matrix Metalloproteinase 12 (MMP-12) Inhibitors as Radiotracers for Positron Emission Tomography.

  2018cites this paper
• Imaging of Tumor Characteristics and Molecular Pathways With PET: Developments Over the Last Decade Toward Personalized Cancer Therapy.

  2018cites this paper
• High-Throughput Approaches to the Development of Molecular Imaging Agents

  2017cites this paper
• Vascular-homing peptides for cancer therapy.

  2017cites this paper
• Tumor-targeting peptides from combinatorial libraries.

  2017cites this paper
• Imaging Matrix Metalloproteinase Activity Implicated in Breast Cancer Progression.

  2016cites this paper
• Active-Site Targeting Paramagnetic Probe for Matrix Metalloproteinases.

  2016cites this paper
• Applications of Hairpin DNA-Functionalized Gold Nanoparticles for Imaging mRNA in Living Cells.

  2016cites this paper
• Breast Cancer

  2016cites this paper
• Bench to bedside molecular functional imaging in translational cancer medicine: to image or to imagine?

  2015cites this paper
• Development of a Novel PET Tracer [18F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging

  2015cites this paper
• Development and preclinical comparison of two non- peptidomimetic MMP/ADAM inhibitors for PET

  2015cites this paper
• Design, (radio)synthesis and applications of radiolabelled matrix metalloproteinase inhibitors for PET

  2015cites this paper
• Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide.

  2015cites this paper
• DNA-functionalized Gold Nanoparticles for Enhanced Molecular Sensing

  2014cites this paper
• Imaging Neuroinflammation – from Bench to Bedside

  2014cites this paper
• Systemic Delivery of Protein Nanocages Bearing CTT Peptides for Enhanced Imaging of MMP-2 Expression in Metastatic Tumor Models

  2014cites this paper
• A comprehensive review on controls in molecular imaging: lessons from MMP-2 imaging.

  2014cites this paper
• Design of radiolabeled gelatinase inhibitor peptide ((99m)Tc-CLP) and evaluation in rats.

  2014cites this paper
• Design of 99mTc‐DTPA‐CLP and Preliminary Evaluation in Rats

  2014influential citation
• Combinatorial peptide libraries: mining for cell-binding peptides.

  2014cites this paper
• Cancer Biology: What’s Important for Imaging

  2014cites this paper
• Advances in Radiotracer Development for Molecular Imaging

  2014cites this paper
• Fluorescence targeted imaging of cancer and bacterial infections

  2014cites this paper
• Nuclear medical molecular imaging of tumor angiogenesis: current status and future prospects.

  2013cites this paper
• University of Groningen Probes for Non-invasive Matrix Metalloproteinase-targeted Imaging with PET and SPECT Matusiak,

  2013cites this paper
• Synthesis and preliminary evaluation in tumor bearing mice of new (18)F-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.

  2013cites this paper
• Probes for non-invasive matrix metalloproteinase-targeted imaging with PET and SPECT.

  2013cites this paper
• Effects of Chelator Modifications on 68Ga-Labeled [Tyr3]Octreotide Conjugates

  2013cites this paper
• RESEARCH ARTICLE Effects of Chelator Modifications on 68 Ga-Labeled (Tyr 3 )Octreotide Conjugates

  2013cites this paper
• Perspectives and potential applications of nanomedicine in breast and prostate cancer

  2013cites this paper
• Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics

  2013cites this paper
• Aptamère de métalloprotéinase matricielle 9 (mmp-9) et ses utilisations

  2013cites this paper
• PET Imaging of Inflammation Biomarkers

  2013cites this paper
• (99m)Tc-MAG3-aptamer for imaging human tumors associated with high level of matrix metalloprotease-9.

  2012cites this paper
• Peptide-Based Selective Inhibitors of Matrix Metalloproteinase-Mediated Activities

  2012cites this paper
• Imaging in the age of molecular medicine: monitoring of anti-angiogenic treatments.

  2012cites this paper
• Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development.

  2012cites this paper
• Development of copper based drugs, radiopharmaceuticals and medical materials

  2012cites this paper
• Molecular imaging in cancer treatment

  2011cites this paper
• Imaging , Diagnosis , Prognosis In Vivo Positron Emission Tomography Imaging of Protease Activity by Generation of a Hydrophobic Product from a Noninhibitory Protease Substrate

  2011cites this paper
• Animal tumor models for PET in drug development

  2011cites this paper
• Studies on 68Ga-Based Agents for PET Imaging of Cancer and Inflammation

  2011cites this paper
• Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide.

  2011cites this paper
• Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.

  2011cites this paper
• Matrix Metalloproteinase-9 is a Diagnostic Marker of Heterotopic Ossification in a Murine Model

  2011influential citation
• Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo

  2011cites this paper
• Intraoperative fluorescence imaging in cancer

  2011cites this paper
• Towards kit-like 18F-labeling of marimastat, a noncovalent inhibitor drug for in vivo PET imaging cancer associated matrix metalloproteases

  2011cites this paper
• Imagerie moléculaire de cellules cancéreuses in vivo

  2011cites this paper
• In Vivo Positron Emission Tomography Imaging of Protease Activity by Generation of a Hydrophobic Product from a Noninhibitory Protease Substrate

  2011cites this paper
• Molecular probes for malignant melanoma imaging.

  2010cites this paper
• Preclinical molecular imaging of tumor angiogenesis.

  2010cites this paper
• Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model.

  2010cites this paper
• Phage display and molecular imaging: expanding fields of vision in living subjects

  2010cites this paper
• Proteomic techniques and activity-based probes for the system-wide study of proteolysis.

  2010cites this paper
• Perspectives andPotential Applications of Nanomedicine inBreastandProstateCancer

  2010cites this paper
• In vitro assessment of liposomal neridronate on MDA-MB-231 human breast cancer cells.

  2010cites this paper
• Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells.

  2009cites this paper
• Development of an optimized activatable MMP-14 targeted SPECT imaging probe.

  2009cites this paper
• Molecular Imaging of Proteases in Cancer.

  2009cites this paper
• PET Imaging of Angiogenesis.

  2009cites this paper
• Radionuclide Imaging of Tumor Angiogenesis

  2009cites this paper
• Fas/FasL interaction of nucleus pulposus and cancer cells with the activation of caspases

  2008cites this paper
• Synthesis of a beta-tetrapeptide analog as a mother compound for the development of matrix metalloproteinase-2-imaging agents.

  2008cites this paper
• Antitumor activities of synthetic and natural stilbenes through antiangiogenic action

  2008cites this paper
• Targeted in vivo imaging of angiogenesis: present status and perspectives.

  2007cites this paper
• A biochemical mechanism for resistance of intervertebral discs to metastatic cancer: Fas ligand produced by disc cells induces apoptotic cell death of cancer cells

  2007cites this paper
• Noninvasive Detection of Matrix Metalloproteinase Activity In Vivo using a Novel Magnetic Resonance Imaging Contrast Agent with a Solubility Switch

  2007cites this paper
• In vivo imaging of experimental stroke : animal models , PET and SPECT radiotracers

  2007cites this paper
• Molecular imaging with copper-64 in the drug discovery and development arena

  2007cites this paper
• Plasmon resonance coupling as a tool for detecting epidermal growth factor receptor expression in cancer

  2007cites this paper
• Update: Imaging Probes Targeting Matrix Metalloproteinases

  2006cites this paper
• How molecular imaging is speeding up antiangiogenic drug development

  2006cites this paper
• PET Imaging of Breast Cancer: Beyond Standard FDG Studies

  2006cites this paper